Merck & Co. Inc. (MRK) Stock: Revenue, Earnings, Margins & Valuation
Merck & Co. Inc. (MRK), USA at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report (FY 2025), visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.
Merck & Co. Inc. key figures (FY 2025)
| Revenue | 65.01 USD bn |
|---|---|
| Gross profit | 55.68 USD bn |
| Operating income | 22.63 USD bn |
| Net income | 16.85 USD bn |
| Net margin | 25.9 % |
Merck & Co. Inc. revenue by segment
| Pharmaceutical | 58.14 USD bn |
|---|---|
| Animal Health | 6.35 USD bn |
Merck & Co. Inc. business model
The income statement of Merck & Co. Inc. is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.